James Eric Callaway
Insider
First SEC filing: Aug. 29, 2017 · Latest: Aug. 29, 2017
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Dec. 6, 2023 | XBIO | A | 2,500 | · | · | 2,500 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 7, 2022 | XBIO | A | 25,000 | · | · | 25,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 7, 2021 | XBIO | A | 25,000 | · | · | 25,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 4, 2020 | XBIO | A | 25,000 | · | · | 25,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 4, 2019 | XBIO | A | 25,000 | · | · | 25,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Nov. 28, 2018 | XBIO | A | 25,000 | · | · | 25,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Oct. 11, 2017 | XBIO | A | 6,250 | · | · | 6,250 Direct | · | Acquired | (price as of 2026-10-02) |
| Oct. 11, 2017 | XBIO | A | 6,250 | · | · | 12,500 Direct | +100.00% | Acquired | (price as of 2026-10-02) |
| Oct. 11, 2017 | XBIO | A | 6,250 | · | · | 18,750 Direct | +50.00% | Acquired | (price as of 2026-10-02) |
| Oct. 11, 2017 | XBIO | A | 6,250 | · | · | 25,000 Direct | +33.33% | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Dec. 6, 2023 | XBIO | Stock Options | Common Stock | $4.29 | Dec. 6, 2033 | 2,500 | Acquired |
| Dec. 7, 2022 | XBIO | Stock Options | Common Stock | $0.44 | Dec. 7, 2032 | 25,000 | Acquired |
| Dec. 7, 2021 | XBIO | Stock Options | Common Stock | $1.44 | Dec. 7, 2031 | 25,000 | Acquired |
| Dec. 4, 2020 | XBIO | Stock Options | Common Stock | $1.10 | Dec. 4, 2030 | 25,000 | Acquired |
| Dec. 4, 2019 | XBIO | Stock Options | Common Stock | $1.31 | Dec. 4, 2029 | 25,000 | Acquired |
| Nov. 28, 2018 | XBIO | Stock Options | Common Stock | $3.05 | Nov. 28, 2028 | 25,000 | Acquired |
| Oct. 11, 2017 | XBIO | Stock Option | Common Stock | $2.95 | Oct. 11, 2027 | 6,250 | Acquired |
| Oct. 11, 2017 | XBIO | Stock Option | Common Stock | $2.95 | Oct. 11, 2027 | 6,250 | Acquired |
| Oct. 11, 2017 | XBIO | Stock Option | Common Stock | $2.95 | Oct. 11, 2027 | 6,250 | Acquired |
| Oct. 11, 2017 | XBIO | Stock Option | Common Stock | $2.95 | Oct. 11, 2027 | 6,250 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Aug. 29, 2017 | XBIO | Common Stock | 0 | Direct |